CO2025002953A2 - Cápsulas blandas de disolución rápida - Google Patents

Cápsulas blandas de disolución rápida

Info

Publication number
CO2025002953A2
CO2025002953A2 CONC2025/0002953A CO2025002953A CO2025002953A2 CO 2025002953 A2 CO2025002953 A2 CO 2025002953A2 CO 2025002953 A CO2025002953 A CO 2025002953A CO 2025002953 A2 CO2025002953 A2 CO 2025002953A2
Authority
CO
Colombia
Prior art keywords
quick
soft capsules
dissolving soft
dissolving
film
Prior art date
Application number
CONC2025/0002953A
Other languages
English (en)
Spanish (es)
Inventor
Qi Fang
Karunakar Sukuru
Aris Gennadios
Soo Ah Jin
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of CO2025002953A2 publication Critical patent/CO2025002953A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CONC2025/0002953A 2022-08-12 2025-03-06 Cápsulas blandas de disolución rápida CO2025002953A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263397554P 2022-08-12 2022-08-12
PCT/US2023/030042 WO2024035911A1 (en) 2022-08-12 2023-08-11 Fast dissolving softgel capsules

Publications (1)

Publication Number Publication Date
CO2025002953A2 true CO2025002953A2 (es) 2025-03-27

Family

ID=89852410

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2025/0002953A CO2025002953A2 (es) 2022-08-12 2025-03-06 Cápsulas blandas de disolución rápida

Country Status (13)

Country Link
US (1) US20250057774A1 (enExample)
EP (1) EP4568657A1 (enExample)
JP (1) JP2025527331A (enExample)
KR (1) KR20250047815A (enExample)
CN (1) CN119907662A (enExample)
AR (1) AR130185A1 (enExample)
AU (1) AU2023321676A1 (enExample)
CA (1) CA3263875A1 (enExample)
CO (1) CO2025002953A2 (enExample)
MX (1) MX2025001366A (enExample)
TW (1) TW202408464A (enExample)
UY (1) UY40394A (enExample)
WO (1) WO2024035911A1 (enExample)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60238269D1 (de) * 2001-11-22 2010-12-23 Morishita Jintan Co Nicht-gelatinöse Kapseln
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
US8231896B2 (en) * 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
KR101288079B1 (ko) * 2010-08-04 2013-07-22 알.피.쉐러 테크놀러지즈 엘엘씨 연질캡슐용 막 형성 조성물
PT2689774T (pt) * 2011-03-21 2019-04-05 Broda Tech Co Ltd Composições de hidrogel termo-reversíveis reversivamente
EP2968081A4 (en) * 2013-03-15 2016-08-10 Banner Life Sciences Llc MOLLE ENTERIC CAPSULES NOT CONTAINING GELATIN
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
CN114667084B (zh) * 2019-10-09 2024-11-15 R.P.谢勒技术有限公司 非动物性软凝胶胶囊制剂、其制备方法及使用方法
CN113332257B (zh) * 2021-06-28 2023-05-05 仙乐健康科技股份有限公司 软胶囊囊壳和软胶囊
KR20240037990A (ko) * 2021-07-06 2024-03-22 알.피.쉐러 테크놀러지즈 엘엘씨 소프트겔 캡슐

Also Published As

Publication number Publication date
AR130185A1 (es) 2024-11-13
EP4568657A1 (en) 2025-06-18
CN119907662A (zh) 2025-04-29
US20250057774A1 (en) 2025-02-20
AU2023321676A1 (en) 2025-03-20
JP2025527331A (ja) 2025-08-20
WO2024035911A9 (en) 2024-12-26
UY40394A (es) 2024-02-15
KR20250047815A (ko) 2025-04-04
WO2024035911A1 (en) 2024-02-15
MX2025001366A (es) 2025-03-07
TW202408464A (zh) 2024-03-01
CA3263875A1 (en) 2024-02-15

Similar Documents

Publication Publication Date Title
ES2421787T3 (es) Forma de dosificación de una vez al día de pramipexol
ES2654062T3 (es) Películas de disolución oral
Green Understanding NSAIDs: from aspirin to COX-2
CN100358509C (zh) 采用hpmc胶囊进行肠和结肠传递
PE20050379A1 (es) Peliculas consumibles por via oral que se disuelven rapidamente que contienen un edulcorante
CO2022005947A2 (es) Formulaciones de cápsulas de gelatina blanda no animales, métodos de preparación y métodos de uso de las mismas
CO6511280A2 (es) Pastillas de gelatina blanda con nicotina
DK0825858T3 (da) Flerumættede omega-3-fedtsyrer til behandling af inflammatorisk tarmsygdom i kapsler med tidsafhængig frigivelse
DE69009755D1 (de) Orale heilmittelform für dauerverabreichung.
BR9912980A (pt) Composição farmacêutica administrável oralmente, utilização de compostos, tablete de mascar e processos para evitar a sìndrome de vazamento anal de óleo
ATE173159T1 (de) Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
CO2025002953A2 (es) Cápsulas blandas de disolución rápida
CN102824333A (zh) 一种口腔速溶膜剂及其制备方法
CU23440B7 (es) Composición de liberación sostenida de pramipexol
WO1999045887A3 (en) Monolithic tablet for controlled drug release
JP2019055969A (ja) 排尿頻度を減少させるための遅延放出製剤およびその使用の方法
FI4101454T3 (fi) Koostumuksia käytettäviksi kohonneen verenpaineen hoitoon
JP2018087217A (ja) 排尿頻度を減少させるための延長放出製剤およびその使用の方法
CO6321129A2 (es) Inhibidor de la cristalizacion y su uso en capsulas de gelatina
BRPI0417695A (pt) cápsulas macias mastigáveis contendo amido não-gelatinizado
CA2499882A1 (en) Modified release dosage form with two cores
PE84399A1 (es) Formas de dosificacion de sertralina de liberacion retardada
JP2013536257A5 (enExample)
PE20230992A1 (es) Formas farmaceuticas de maleato de acalabrutinib
CA2449520A1 (en) Swallow tablet comprising paracetamol